These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 34764115

  • 1. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use.
    Fujihara N, Hamada S, Yoshida M, Tsukushi S.
    BMJ Case Rep; 2021 Nov 11; 14(11):. PubMed ID: 34764115
    [Abstract] [Full Text] [Related]

  • 2. Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius.
    Li Z, Deng Z, Yang Y, Gao D, Zhang Q, Niu X, Liu W.
    J Orthop Surg Res; 2024 Sep 28; 19(1):607. PubMed ID: 39342379
    [Abstract] [Full Text] [Related]

  • 3. Denosumab Does Not Decrease Local Recurrence in Giant Cell Tumor of Bone Treated With En Bloc Resection.
    Tsukamoto S, Mavrogenis AF, Tanaka Y, Kido A, Kawaguchi M, Errani C.
    Orthopedics; 2021 Sep 28; 44(6):326-332. PubMed ID: 34618637
    [Abstract] [Full Text] [Related]

  • 4. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC.
    Orthop Surg; 2019 Dec 28; 11(6):1101-1108. PubMed ID: 31762217
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q, Lu J, Zhu X, Song G, Wu H, Xu H, Wang A, Wang J.
    Eur Spine J; 2023 Dec 28; 32(12):4297-4305. PubMed ID: 37318598
    [Abstract] [Full Text] [Related]

  • 6. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation.
    Tsukamoto S, Hindiskere S, Honoki K, Mavrogenis AF, Tanaka Y, Chinder PS, Donati DM, Errani C.
    Int Orthop; 2023 Jan 28; 47(1):265-273. PubMed ID: 36282294
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 28; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 8. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS.
    Bone Joint J; 2021 Jan 28; 103-B(1):184-191. PubMed ID: 33380180
    [Abstract] [Full Text] [Related]

  • 9. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
    Duan DK, Zhang GC, Sun BJ, Ma TX, Zhao M.
    Eur Rev Med Pharmacol Sci; 2023 Jun 28; 27(11):5039-5052. PubMed ID: 37318478
    [Abstract] [Full Text] [Related]

  • 10. Giant cell tumour of bone in the denosumab era.
    van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H.
    Eur J Cancer; 2017 May 28; 77():75-83. PubMed ID: 28365529
    [Abstract] [Full Text] [Related]

  • 11. Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity.
    Tsukamoto S, Mavrogenis AF, Hindiskere S, Honoki K, Kido A, Fujii H, Masunaga T, Tanaka Y, Chinder PS, Donati DM, Errani C.
    Curr Oncol; 2022 Sep 05; 29(9):6383-6399. PubMed ID: 36135072
    [Abstract] [Full Text] [Related]

  • 12. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
    Sambri A, Medellin MR, Errani C, Campanacci L, Fujiwara T, Donati D, Parry M, Grimer R.
    J Orthop Sci; 2020 May 05; 25(3):513-519. PubMed ID: 31155442
    [Abstract] [Full Text] [Related]

  • 13. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS.
    Clin Orthop Relat Res; 2020 Nov 05; 478(11):2522-2533. PubMed ID: 32401001
    [Abstract] [Full Text] [Related]

  • 14. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
    Duan PG, Sheng YH, Deng CH, Tang BY, Yao HQ.
    BMC Musculoskelet Disord; 2020 Feb 15; 21(1):105. PubMed ID: 32061254
    [Abstract] [Full Text] [Related]

  • 15. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA.
    Clin Orthop Relat Res; 2018 Sep 15; 476(9):1783-1790. PubMed ID: 30778015
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.
    World J Surg Oncol; 2018 Aug 08; 16(1):160. PubMed ID: 30089488
    [Abstract] [Full Text] [Related]

  • 17. Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery.
    Asano N, Saito M, Kobayashi E, Morii T, Kikuta K, Watanabe I, Anazawa U, Takeuchi K, Suzuki Y, Susa M, Nishimoto K, Ishii R, Miyazaki N, Mrioka H, Kawai A, Horiuchi K, Nakayama R.
    Ann Surg Oncol; 2022 Jun 08; 29(6):3992-4000. PubMed ID: 35175454
    [Abstract] [Full Text] [Related]

  • 18. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.
    Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, Vaz G, Wunder JS, Seeger LL, Feng A, Roberts ZJ, Bach BA.
    Ann Surg Oncol; 2015 Sep 08; 22(9):2860-8. PubMed ID: 26033180
    [Abstract] [Full Text] [Related]

  • 19. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 20. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum.
    Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J.
    Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.